Wenn die Tage kürzer und trüber werden, verdunkelt sich häufig auch die Stimmung. Manche Menschen werden sogar ausgesprochen depressiv. Sie fühlen sich niedergeschlagen, können sich zu nichts aufraffen und haben nicht einmal Lust, sich zu bewegen. Sie entwickeln Heißhunger auf Süßigkeiten, Nudeln, Kartoffeln und andere kohlenhydrathaltige Speisen, legen an Gewicht zu und würden am liebsten […]
Related Posts
The Impacts of Asthma Go Beyond Physical Health
The Asthma and Allergy Foundation of America (AAFA) conducted the My Life With Asthma survey to highlight the challenges people with asthma, especially severe asthma, face. We found that people with asthma have concerns beyond their physical health. Ma…
The Svelte Physician – How Podio Can Boost Collaboration And Declutter Your Workday
I was recently talking to a friend, a young GP, who had just spent two hours on the phone figuring out how to help a patient with unusual symptoms. He told me he had been going through his address book of colleagues and physicians in different fields who could help with this particularly difficult referral. In the end, he had five different suggestions, three coming from cardiologists and was left with no idea on how to compare these discordant opinions. It sounded slightly surreal, like Richard Burton broodily looking through a list of old lovers, wondering who to call for advice on true love (something that had always eluded him). The blondes would give different advice than the brunettes. Bemused by this image, I was redrawn to the idea of how collaboration tools could benefit such situations, particularly how they could be used to ease communication between physicians. As we know, hospitals and group practices are very particular organizations, quite traditional in their form, and subject to stringent rules and regulations when it comes to sharing information. Medical knowledge is confined to different areas of expertise, both by professional division and departmental delineations. However, the competence necessary to solve patients’ […]
Acne inversa: Adalimumab jetzt auch für Jugendliche
Adalimumab (Humira®) hat bereits im Dezember von der Europäischen Kommission die Zulassungserweiterung zur Behandlung der mittelschweren bis schweren aktiven Acne inversa (AI) bei Jugendlichen ab 12 Jahren erhalten, teilt das Unternehmen AbbVie mit. … lesen Sie weiter! Quelle: : http://www.aerztezeitung.de/medizin/krankheiten/haut-krankheiten/article/929486/acne-inversa-adalimumab-jetzt-jugendliche.html